Corneal angiography for guiding and evaluating fine-needle diathermy treatment of corneal neovascularization.

PURPOSE To investigate the outcome of selective occlusion of the afferent vessel of corneal neovascular complexes (CoNVs), using angiographically guided fine-needle diathermy (FND). DESIGN Retrospective interventional case series. SUBJECTS Patients with CoNV unresponsive to topical steroid therapy. METHODS Visual acuity, color images, and fluorescein angiography and indocyanine green angiography were measured before and after FND with a minimum of 3 months of follow-up. The number of afferent vessels crossing the limbus, time to fluorescein leakage, area, and geometric properties of the CoNV were determined using an in-house automated program written in numerical computing language (MatLab R14; The MathWorks Inc., Natick, MA). The location of the afferent vessel was identified from the angiographic images and marked at the slit lamp using a needle to make a cut to the depth of the vessel. We then applied FND using an electrolysis needle. MAIN OUTCOME MEASURES Area of CoNV. RESULTS Thirty patients underwent FND for CoNV that had not responded to treatment with topical steroids. The CoNV was associated with previous microbial keratitis (n = 26), intrastromal corneal ring segments (n = 2), ectodermal dysplasia (n = 1), and corneal choristoma (n = 1). Duration of CoNV was >6 months in 23 patients (77%), between 3 and 6 months in 3 patients (10%), and <3 months in 5 patients (13%). The number of afferent vessels per CoNV ranged from 1 to 3, with a mean diameter of 40 μm (standard deviation [SD], 10 μm) and mean time to leakage from apical vessels was 44.22 seconds (minimum, 27.43 seconds; maximum, 63.59 seconds). The number of FND treatments that were required was 1 for 20 patients (66.6%), 2 for 8 patients (26.6%), and 3 for 2 patients (6.6%). After FND, the area of CoNV reduced by 1.80 mm(2) (SD, 1.40 mm(2)), from 2.42 (SD, 1.59) to 0.62 mm(2) (SD, 0.73 mm(2)) up to 12 weeks postoperatively (P < 0.01). CONCLUSIONS The differentiation of afferent and efferent vessels using corneal angiography enables treatment to be selectively applied to the afferent vessels; there are usually 1 to 2 for each CoNV complex.

[1]  Yalin Zheng,et al.  Imaging and evaluation of corneal vascularization using fluorescein and indocyanine green angiography. , 2012, Investigative ophthalmology & visual science.

[2]  J. Marshall,et al.  Keratorefractive effect of microwave keratoplasty on human corneas , 2010, Journal of cataract and refractive surgery.

[3]  Yalin Zheng,et al.  Marginal corneal vascular arcades. , 2013, Investigative ophthalmology & visual science.

[4]  D. Azar,et al.  Corneal neovascularization. , 2001, Current opinion in ophthalmology.

[5]  H. Dua,et al.  Fine needle diathermy occlusion of corneal vessels , 2014, British Journal of Ophthalmology.

[6]  C. Kucukerdonmez,et al.  The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization , 2013, Acta ophthalmologica.

[7]  C. Cursiefen,et al.  Topical Ranibizumab inhibits inflammatory corneal hem‐ and lymphangiogenesis , 2014, Acta ophthalmologica.

[8]  Yalin Zheng,et al.  Quantifying changes in corneal neovascularization using fluorescein and indocyanine green angiography. , 2012, American journal of ophthalmology.

[9]  Zhang Chaoran,et al.  Combination of vascular endothelial growth factor receptor/platelet-derived growth factor receptor inhibition markedly improves the antiangiogenic efficacy for advanced stage mouse corneal neovascularization , 2011, Graefe's Archive for Clinical and Experimental Ophthalmology.

[10]  U. Schlötzer-Schrehardt,et al.  Pericyte recruitment in human corneal angiogenesis: an ultrastructural study with clinicopathological correlation , 2003, The British journal of ophthalmology.

[11]  S. Thatte Fine needle diathermy - a choice for managing corneal vascularization. , 2011, Nepalese journal of ophthalmology : a biannual peer-reviewed academic journal of the Nepal Ophthalmic Society : NEPJOPH.

[12]  W Ellis,et al.  Experimental radial thermokeratoplasty in rabbits. , 1990, Archives of ophthalmology.

[13]  P. Chévez-Barrios,et al.  Inhibition of experimental corneal neovascularisation by bevacizumab (Avastin) , 2006, British Journal of Ophthalmology.

[14]  E. Manche,et al.  Regression of effect over long‐term follow‐up of conductive keratoplasty to correct mild to moderate hyperopia , 2009, Journal of cataract and refractive surgery.

[15]  R. Dana,et al.  Inflammatory Corneal Neovascularization: Etiopathogenesis , 2011, Seminars in ophthalmology.

[16]  T. Yoshitomi,et al.  Cauterization of Central Cornea Induces Recruitment of Major Histocompatibility Complex Class II+ Langerhans Cells From Limbal Basal Epithelium , 2010, Cornea.

[17]  F. Kruse,et al.  Angioregressive Pretreatment of Mature Corneal Blood Vessels Before Keratoplasty: Fine-Needle Vessel Coagulation Combined With Anti-VEGFs , 2012, Cornea.

[18]  D. Gupta,et al.  Treatments for Corneal Neovascularization: A Review. , 2011, Cornea.

[19]  R. Dana,et al.  Safety and efficacy of the multitargeted receptor kinase inhibitor pazopanib in the treatment of corneal neovascularization. , 2013, Investigative ophthalmology & visual science.

[20]  D. Anderson,et al.  Long-term outcomes of Fine Needle Diathermy for established corneal neovascularisation , 2014, British Journal of Ophthalmology.

[21]  V. Romano,et al.  Angiographic-guided treatment of corneal neovascularization. , 2015, JAMA ophthalmology.

[22]  M. Goggin,et al.  Fluorescein angiographic monitoring of corneal vascularization in lipid keratopathy , 2004, Clinical & experimental ophthalmology.